Search for: "TEVA PHARMACEUTICALS USA, INC." Results 221 - 240 of 482
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2024, 3:43 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., 23-768 (Supreme Court). [read post]
29 Mar 2016, 7:21 am by Green and Associates
Reinstein agreed to switch his patients to the generic version, but only after its manufacturers, Teva Pharmaceuticals USA Inc. and IVAX Pharmaceuticals LLC, agreed to pay him a consulting fee and finance a Clozapine research study performed by a Reinstein-affiliated entity. [read post]
21 Apr 2014, 6:01 am by Jon Gelman
The cost for medical delivery far exceeds indemnification for temporary and permanent disability benefits.The court's action, albeit temporary in nature, maybe a signal of forthcoming judicial intervention in the pharmaceutical arena that will result in a more realistic cost for pharmaceutical benefits in workers' compensation.Teva Pharmaceuticals USA, Inc., et al., Petitioners v.Sandoz, Inc., et al. [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
13 Jun 2017, 12:00 pm by Sheppard Mullin
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
13 Jun 2017, 12:00 pm by Daniel Taskalis
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
25 Jun 2018, 7:03 am by Dennis Crouch
Teva Pharmaceuticals USA Inc., Docket No. 17-1229. [read post]
17 Oct 2014, 5:09 pm by Oyez Project
Stephens Teva Pharmaceuticals USA, Inc., v. [read post]
2 Nov 2020, 1:41 pm by Courtenay C. Brinckerhoff
Teva Pharmaceuticals USA, Inc., is getting attention for potentially “endangering” the practice of skinny labelling. [read post]